• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $VGR

    Vector Group Ltd.

    Subscribe to $VGR
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care

    Vector Group Ltd., through its subsidiaries, manufactures and sells cigarettes in the United States. It operates in two segments, Tobacco and Real Estate. The company produces cigarettes in 100 combinations under the EAGLE 20's, Pyramid, Montego, Grand Prix, Liggett Select, Eve, and USA brand names, as well as various partner and private label brands. In addition, it provides residential real estate brokerage, relocation, real estate sales and marketing, and title insurance services to real estate buyers and financial institutions; manages cooperative apartment buildings, condominium apartment buildings, and rental apartment buildings; and invests in, acquires, and owns real estate properties or projects, as well as develops land. Further, the company operates elliman.com, a website that enables consumers to search properties and access current market information, as well as offers building and neighborhood guides, and other interactive content. It markets and sells its cigarettes to wholesalers and distributors of tobacco and convenience products, as well as grocery, drug, and convenience store chains. The company was formerly known as Brooke Group Ltd. and changed its name to Vector Group Ltd. in May 2000. Vector Group Ltd. was founded in 1873 and is based in Miami, Florida.

    IPO Year:

    Exchange: NYSE

    Website: vectorgroupltd.com

    Peers

    $VACQ
    $VAQC

    Recent Analyst Ratings for Vector Group Ltd.

    DatePrice TargetRatingAnalyst
    3/31/2022$12.00 → $16.00Equal Weight → Overweight
    Barclays
    11/15/2021$13.00 → $17.00Underweight → Equal Weight
    Barclays
    11/9/2021$18.00Perform → Outperform
    Oppenheimer
    9/13/2021$15.00 → $13.00Equal Weight → Underweight
    Barclays
    See more ratings

    Vector Group Ltd. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hims & Hers Health Set to Join S&P SmallCap 600

      NEW YORK, Oct. 4, 2024 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE:HIMS) will replace Vector Group Ltd (NYSE:VGR) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, October 9. JT Group is acquiring Vector Group in a deal expected to close soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector October 9, 2024 S&P SmallCap 600 Addition Hims & Hers Health HIMS Health Care S&P SmallCap 600 Deletion Vector Group VGR Consumer Staples For more information about S&P Dow Jones Indices, please visit www.spdji.com

      10/4/24 6:05:00 PM ET
      $HIMS
      $SPGI
      $VGR
      Medical/Nursing Services
      Health Care
      Finance: Consumer Services
      Finance
    • Vector Group Announces Agreement to be Acquired by JT Group

      Delivers significant value for stockholders while positioning Vector Group for long-term success Vector Group Ltd. (NYSE:VGR) today announced that it has entered into a definitive agreement to be acquired by JT Group, a global company headquartered in Tokyo, Japan, operating in tobacco, pharmaceuticals and processed food. JT Group's global tobacco business, headquartered in Geneva, Switzerland, manufactures and sells some of the world's best-known brands in over 130 markets worldwide – including Winston and Camel (outside the U.S.), as well as MEVIUS and LD. Under the terms of the agreement, JT Group will offer to acquire all outstanding shares of Vector Group common stock for $15.00 pe

      8/21/24 6:00:00 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group Declares Quarterly Cash Dividend

      Vector Group Ltd. (NYSE:VGR) today announced that its Board of Directors has declared a regular quarterly cash dividend on its common stock of $0.20 per share. The quarterly cash dividend will be payable on September 12, 2024, to holders of record as of August 30, 2024. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's website, www.VectorGroupLtd.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240819252290/en/

      8/20/24 3:08:00 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group Reports Second Quarter 2024 Financial Results

      Montego maintains position as largest discount brand in the U.S. Second Quarter 2024 Highlights: Consolidated revenues of $371.9 million, up 1.7% or $6.3 million compared to the prior year period. Tobacco segment wholesale market share increased to 5.7% from 5.4% in the prior year period and retail market share remained at 5.8%, unchanged from the prior year period. Montego wholesale and retail market share both increased to 4.1% from 3.4% and 3.5%, respectively, in the prior year period. Operating income of $97.8 million, up 36.5% or $26.1 million compared to the prior year period. Tobacco segment operating income of $102.9 million, up 37.0% or $27.8 million compared to t

      7/31/24 4:45:00 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group to Host Second Quarter 2024 Results Conference Call

      Vector Group Ltd. (NYSE:VGR) will conduct a conference call and webcast to discuss its second quarter 2024 results on Thursday, August 1, 2024 at 8:00 a.m. (ET). Investors may access the call via live webcast at https://www.webcaster4.com/Webcast/Page/2271/50954. Please join the webcast at least 10 minutes prior to start time. A replay of the call will be available shortly after the call ends on August 1, 2024 through August 15, 2024 at https://www.webcaster4.com/Webcast/Page/2271/50954. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's website, www.VectorGroupLtd.

      7/25/24 8:00:00 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group Declares Quarterly Cash Dividend

      Vector Group Ltd. (NYSE:VGR) today announced that its Board of Directors has declared a regular quarterly cash dividend on its common stock of $0.20 per share. The quarterly cash dividend will be payable on June 14, 2024, to holders of record as of June 5, 2024. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's website, www.VectorGroupLtd.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240516413421/en/

      5/16/24 12:06:00 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group Reports First Quarter 2024 Financial Results

      Continued Strong Earnings Growth in Tobacco Segment First Quarter 2024 Highlights: Consolidated revenues of $324.6 million, down 2.9% or $9.6 million compared to the prior year period. Tobacco segment revenues of $324.6 million, down 2.9% or $9.6 million compared to the prior year period. Tobacco segment wholesale market share declined to 5.6% from 5.7% in the prior year period and retail market share remained at 5.8%, unchanged from the prior year period. Montego wholesale market share increased to 3.9% from 3.3% in the prior year period and retail market share increased to 4.0% from 3.4% in the prior year period. Reported operating income of $77.8 million, up 4.7% or $3

      5/1/24 4:17:00 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group to Host First Quarter 2024 Results Conference Call

      Vector Group Ltd. (NYSE:VGR) will conduct a conference call and webcast to discuss its first quarter 2024 results on Thursday, May 2, 2024 at 8:00 a.m. (ET). Investors may access the call via live webcast at https://www.webcaster4.com/Webcast/Page/2271/50471. Please join the webcast at least 10 minutes prior to start time. A replay of the call will be available shortly after the call ends on May 2, 2024 through May 16, 2024 at https://www.webcaster4.com/Webcast/Page/2271/50471. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's website, www.VectorGroupLtd.com. View

      4/25/24 8:00:00 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group Declares Quarterly Cash Dividend

      Vector Group Ltd. (NYSE:VGR) today announced that its Board of Directors has declared a regular quarterly cash dividend on its common stock of $0.20 per share. The quarterly cash dividend will be payable on March 14, 2024, to holders of record as of March 4, 2024. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's website, www.VectorGroupLtd.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240215601440/en/

      2/15/24 12:41:00 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group Reports Fourth Quarter and Full Year 2023 Financial Results

      Montego maintains position as largest discount brand in the U.S. Fourth Quarter 2023 Highlights: Consolidated revenues of $360.4 million, down 0.9% or $3.4 million compared to the prior year period. Tobacco segment wholesale market share increased to 5.7% from 5.5% in the prior year period and retail market share remained at 5.8% in the current period. Montego wholesale market share increased to 3.8% from 3.0% in the prior year period and retail market share increased to 3.8% from 3.2% in the prior year period. Operating income of $91.6 million, up 2.6% or $2.3 million compared to the prior year period. Tobacco segment operating income of $98.1 million, up 5.6% or $5.2 mil

      2/13/24 4:30:00 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care

    Vector Group Ltd. Financials

    Live finance-specific insights

    See more
    • Vector Group Declares Quarterly Cash Dividend

      Vector Group Ltd. (NYSE:VGR) today announced that its Board of Directors has declared a regular quarterly cash dividend on its common stock of $0.20 per share. The quarterly cash dividend will be payable on September 12, 2024, to holders of record as of August 30, 2024. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's website, www.VectorGroupLtd.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240819252290/en/

      8/20/24 3:08:00 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group Reports Second Quarter 2024 Financial Results

      Montego maintains position as largest discount brand in the U.S. Second Quarter 2024 Highlights: Consolidated revenues of $371.9 million, up 1.7% or $6.3 million compared to the prior year period. Tobacco segment wholesale market share increased to 5.7% from 5.4% in the prior year period and retail market share remained at 5.8%, unchanged from the prior year period. Montego wholesale and retail market share both increased to 4.1% from 3.4% and 3.5%, respectively, in the prior year period. Operating income of $97.8 million, up 36.5% or $26.1 million compared to the prior year period. Tobacco segment operating income of $102.9 million, up 37.0% or $27.8 million compared to t

      7/31/24 4:45:00 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group to Host Second Quarter 2024 Results Conference Call

      Vector Group Ltd. (NYSE:VGR) will conduct a conference call and webcast to discuss its second quarter 2024 results on Thursday, August 1, 2024 at 8:00 a.m. (ET). Investors may access the call via live webcast at https://www.webcaster4.com/Webcast/Page/2271/50954. Please join the webcast at least 10 minutes prior to start time. A replay of the call will be available shortly after the call ends on August 1, 2024 through August 15, 2024 at https://www.webcaster4.com/Webcast/Page/2271/50954. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's website, www.VectorGroupLtd.

      7/25/24 8:00:00 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group Declares Quarterly Cash Dividend

      Vector Group Ltd. (NYSE:VGR) today announced that its Board of Directors has declared a regular quarterly cash dividend on its common stock of $0.20 per share. The quarterly cash dividend will be payable on June 14, 2024, to holders of record as of June 5, 2024. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's website, www.VectorGroupLtd.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240516413421/en/

      5/16/24 12:06:00 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group Reports First Quarter 2024 Financial Results

      Continued Strong Earnings Growth in Tobacco Segment First Quarter 2024 Highlights: Consolidated revenues of $324.6 million, down 2.9% or $9.6 million compared to the prior year period. Tobacco segment revenues of $324.6 million, down 2.9% or $9.6 million compared to the prior year period. Tobacco segment wholesale market share declined to 5.6% from 5.7% in the prior year period and retail market share remained at 5.8%, unchanged from the prior year period. Montego wholesale market share increased to 3.9% from 3.3% in the prior year period and retail market share increased to 4.0% from 3.4% in the prior year period. Reported operating income of $77.8 million, up 4.7% or $3

      5/1/24 4:17:00 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group to Host First Quarter 2024 Results Conference Call

      Vector Group Ltd. (NYSE:VGR) will conduct a conference call and webcast to discuss its first quarter 2024 results on Thursday, May 2, 2024 at 8:00 a.m. (ET). Investors may access the call via live webcast at https://www.webcaster4.com/Webcast/Page/2271/50471. Please join the webcast at least 10 minutes prior to start time. A replay of the call will be available shortly after the call ends on May 2, 2024 through May 16, 2024 at https://www.webcaster4.com/Webcast/Page/2271/50471. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's website, www.VectorGroupLtd.com. View

      4/25/24 8:00:00 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group Declares Quarterly Cash Dividend

      Vector Group Ltd. (NYSE:VGR) today announced that its Board of Directors has declared a regular quarterly cash dividend on its common stock of $0.20 per share. The quarterly cash dividend will be payable on March 14, 2024, to holders of record as of March 4, 2024. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's website, www.VectorGroupLtd.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240215601440/en/

      2/15/24 12:41:00 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group Reports Fourth Quarter and Full Year 2023 Financial Results

      Montego maintains position as largest discount brand in the U.S. Fourth Quarter 2023 Highlights: Consolidated revenues of $360.4 million, down 0.9% or $3.4 million compared to the prior year period. Tobacco segment wholesale market share increased to 5.7% from 5.5% in the prior year period and retail market share remained at 5.8% in the current period. Montego wholesale market share increased to 3.8% from 3.0% in the prior year period and retail market share increased to 3.8% from 3.2% in the prior year period. Operating income of $91.6 million, up 2.6% or $2.3 million compared to the prior year period. Tobacco segment operating income of $98.1 million, up 5.6% or $5.2 mil

      2/13/24 4:30:00 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group to Host Fourth Quarter and Full Year 2023 Results Conference Call

      Vector Group Ltd. (NYSE:VGR) will conduct a conference call and webcast to discuss its fourth quarter and full year 2023 results on Wednesday, February 14, 2024 at 8:00 a.m. (ET). Investors may access the call via live webcast at https://www.webcaster4.com/Webcast/Page/2271/49823. Please join the webcast at least 10 minutes prior to start time. A replay of the call will be available shortly after the call ends on February 14, 2024 through February 28, 2024 at https://www.webcaster4.com/Webcast/Page/2271/49823. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's websi

      2/7/24 8:00:00 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group Declares Quarterly Cash Dividend

      Vector Group Ltd. (NYSE:VGR) today announced that its Board of Directors has declared a regular quarterly cash dividend on its common stock of $0.20 per share. The quarterly cash dividend will be payable on December 15, 2023, to holders of record as of December 1, 2023. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's website, www.VectorGroupLtd.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20231121464861/en/

      11/21/23 11:30:00 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care

    Vector Group Ltd. Leadership Updates

    Live Leadership Updates

    See more
    • Hims & Hers Health Set to Join S&P SmallCap 600

      NEW YORK, Oct. 4, 2024 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE:HIMS) will replace Vector Group Ltd (NYSE:VGR) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, October 9. JT Group is acquiring Vector Group in a deal expected to close soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector October 9, 2024 S&P SmallCap 600 Addition Hims & Hers Health HIMS Health Care S&P SmallCap 600 Deletion Vector Group VGR Consumer Staples For more information about S&P Dow Jones Indices, please visit www.spdji.com

      10/4/24 6:05:00 PM ET
      $HIMS
      $SPGI
      $VGR
      Medical/Nursing Services
      Health Care
      Finance: Consumer Services
      Finance
    • Douglas Elliman Appoints Richard Ferrari as President and CEO of Brokerage for New York City and the Northeast Region

      Yuval Greenblatt and Alfred Renna Promoted to Senior Managing Director of Operations and Senior Managing Director of Sales, Respectively, for Flagship 575 Madison Avenue Office Douglas Elliman, one of the largest residential real estate brokerages in the United States, announced today that real estate veteran Richard Ferrari has joined the firm as President and CEO of Brokerage for New York City and the Northeast Region. In this role, Ferrari, a highly regarded industry expert, will oversee the firm's New York City resale markets, including Manhattan, Brooklyn, Riverdale and Long Island City in Queens. He will also assume responsibility for Elliman's New Jersey, Westchester, Connecticut a

      7/21/21 8:30:00 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group Appoints Technology Veteran Wilson L. White to its Board of Directors

      Expands Board to 10 Directors with Addition of Silicon Valley Executive Vector Group Ltd. (NYSE:VGR) (the "Company") today announced that it has appointed technology industry veteran, Wilson L. White, to its Board of Directors, effective immediately. Mr. White currently serves as Senior Director of Government Affairs and Public Policy at Google. With Mr. White's appointment, Vector Group's Board expands to 10 directors. "With many years of experience in the technology industry, including government relations and legal expertise, Wilson brings to the Board a unique skillset that will further strengthen Vector Group's commitment to staying at the forefront of our business' rapidly-evolving

      6/22/21 8:00:00 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group Appoints Richard J. Lampen as Chief Operating Officer and Member of the Board of Directors

      MIAMI--(BUSINESS WIRE)--Vector Group Ltd. (NYSE: VGR) (the “Company”) today announced that it has appointed its current Executive Vice President Richard J. Lampen to the additional position of Chief Operating Officer (COO) and to serve as a member of the Board of Directors, effective immediately. “On behalf of the Board and Management team, we are pleased to announce Dick’s new roles at Vector Group,” said Howard M. Lorber, President and Chief Executive Officer of Vector Group. “With his broad executive experience and deep operational understanding of the company, having served in a variety of senior leadership roles for Vector Group and its affiliates for more than 25 years, Dick

      1/14/21 4:57:00 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care

    Vector Group Ltd. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Vector Grp upgraded by Barclays with a new price target

      Barclays upgraded Vector Grp from Equal Weight to Overweight and set a new price target of $16.00 from $12.00 previously

      3/31/22 7:41:06 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Grp upgraded by Barclays with a new price target

      Barclays upgraded Vector Grp from Underweight to Equal Weight and set a new price target of $17.00 from $13.00 previously

      11/15/21 8:00:05 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group upgraded by Oppenheimer with a new price target

      Oppenheimer upgraded Vector Group from Perform to Outperform and set a new price target of $18.00

      11/9/21 6:13:20 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Grp downgraded by Barclays with a new price target

      Barclays downgraded Vector Grp from Equal Weight to Underweight and set a new price target of $13.00 from $15.00 previously

      9/13/21 7:40:27 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care

    Vector Group Ltd. SEC Filings

    See more
    • SEC Form 15-12G filed by Vector Group Ltd.

      15-12G - VECTOR GROUP LTD (0000059440) (Filer)

      10/17/24 8:00:07 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form EFFECT filed by Vector Group Ltd.

      EFFECT - VECTOR GROUP LTD (0000059440) (Filer)

      10/8/24 12:15:04 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form EFFECT filed by Vector Group Ltd.

      EFFECT - VECTOR GROUP LTD (0000059440) (Filer)

      10/8/24 12:15:08 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form EFFECT filed by Vector Group Ltd.

      EFFECT - VECTOR GROUP LTD (0000059440) (Filer)

      10/8/24 12:15:05 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form EFFECT filed by Vector Group Ltd.

      EFFECT - VECTOR GROUP LTD (0000059440) (Filer)

      10/8/24 12:15:11 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form EFFECT filed by Vector Group Ltd.

      EFFECT - VECTOR GROUP LTD (0000059440) (Filer)

      10/8/24 12:15:03 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form EFFECT filed by Vector Group Ltd.

      EFFECT - VECTOR GROUP LTD (0000059440) (Filer)

      10/8/24 12:15:07 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form EFFECT filed by Vector Group Ltd.

      EFFECT - VECTOR GROUP LTD (0000059440) (Filer)

      10/8/24 12:15:12 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form EFFECT filed by Vector Group Ltd.

      EFFECT - VECTOR GROUP LTD (0000059440) (Filer)

      10/8/24 12:15:13 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form EFFECT filed by Vector Group Ltd.

      EFFECT - VECTOR GROUP LTD (0000059440) (Filer)

      10/8/24 12:15:09 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care

    Vector Group Ltd. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Vector Group Ltd.

      SC 13D/A - VECTOR GROUP LTD (0000059440) (Subject)

      10/15/24 4:00:16 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Vector Group Ltd.

      SC 13D/A - VECTOR GROUP LTD (0000059440) (Subject)

      10/7/24 8:43:24 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Vector Group Ltd.

      SC 13D/A - VECTOR GROUP LTD (0000059440) (Subject)

      10/1/24 4:27:47 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Vector Group Ltd.

      SC 13D/A - VECTOR GROUP LTD (0000059440) (Subject)

      8/22/24 5:52:56 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D filed by Vector Group Ltd.

      SC 13D - VECTOR GROUP LTD (0000059440) (Subject)

      2/16/24 5:21:58 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by Vector Group Ltd. (Amendment)

      SC 13G/A - VECTOR GROUP LTD (0000059440) (Subject)

      2/13/24 5:16:09 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by Vector Group Ltd. (Amendment)

      SC 13G/A - VECTOR GROUP LTD (0000059440) (Subject)

      2/9/24 5:46:33 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by Vector Group Ltd. (Amendment)

      SC 13G/A - VECTOR GROUP LTD (0000059440) (Subject)

      2/13/23 3:32:27 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by Vector Group Ltd. (Amendment)

      SC 13G/A - VECTOR GROUP LTD (0000059440) (Subject)

      2/13/23 1:35:25 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by Vector Group Ltd. (Amendment)

      SC 13G/A - VECTOR GROUP LTD (0000059440) (Subject)

      2/11/22 3:52:58 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care

    Vector Group Ltd. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Watkins Barry returned $225,000 worth of shares to the company (15,000 units at $15.00), closing all direct ownership in the company (SEC Form 4)

      4 - VECTOR GROUP LTD (0000059440) (Issuer)

      10/7/24 9:41:06 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Officer Bell Marc N was granted 164,500 shares and returned $5,100,000 worth of shares to the company (340,000 units at $15.00), closing all direct ownership in the company (SEC Form 4)

      4 - VECTOR GROUP LTD (0000059440) (Issuer)

      10/7/24 9:14:02 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Sharpe Jean E returned $225,000 worth of shares to the company (15,000 units at $15.00), closing all direct ownership in the company (SEC Form 4)

      4 - VECTOR GROUP LTD (0000059440) (Issuer)

      10/7/24 9:08:43 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Beinstein Henry C returned $225,000 worth of shares to the company (15,000 units at $15.00), closing all direct ownership in the company (SEC Form 4)

      4 - VECTOR GROUP LTD (0000059440) (Issuer)

      10/7/24 9:07:26 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Officer Ballard James D returned $581,250 worth of shares to the company (38,750 units at $15.00), closing all direct ownership in the company (SEC Form 4)

      4 - VECTOR GROUP LTD (0000059440) (Issuer)

      10/7/24 9:04:01 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Officer Kirkland J Bryant Iii was granted 164,500 shares and returned $5,100,000 worth of shares to the company (340,000 units at $15.00), closing all direct ownership in the company (SEC Form 4)

      4 - VECTOR GROUP LTD (0000059440) (Issuer)

      10/7/24 8:59:28 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • EVP/COO Lampen Richard returned $9,112,500 worth of shares to the company (607,500 units at $15.00) and was granted 292,500 shares, closing all direct ownership in the company (SEC Form 4)

      4 - VECTOR GROUP LTD (0000059440) (Issuer)

      10/7/24 8:58:39 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Carlucci Paul V returned $225,000 worth of shares to the company (15,000 units at $15.00), closing all direct ownership in the company (SEC Form 4)

      4 - VECTOR GROUP LTD (0000059440) (Issuer)

      10/7/24 8:57:08 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Bernstein Ronald J closing all direct ownership in the company (SEC Form 4)

      4 - VECTOR GROUP LTD (0000059440) (Issuer)

      10/7/24 8:56:47 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • President and CEO Lorber Howard M was granted 1,205,500 shares and returned $30,825,000 worth of shares to the company (2,055,000 units at $15.00), closing all direct ownership in the company (SEC Form 4)

      4 - VECTOR GROUP LTD (0000059440) (Issuer)

      10/7/24 8:55:41 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care